Addiction & Substance Use

Caffeine use is higher in smokers and in adults with serious mental illness. How does this impact patients with bipolar disorder and schizophrenia?

One doctor’s experience with patient suicide.

Patients with serious mental illness and substance use disorders are expected to be particularly affected by these changes.

From the impact of patients’ overdose deaths on physicians to addressing America’s mental health crisis, here are highlights from the week in Psychiatric Times.

A patient loss does not undo or discard the multitude of meaningful life changing and life preserving work done.

Remember to keep the cart behind the horse while practicing medicine.

Smoking and drinking (caffeine): Researchers analyzed caffeine intake and levels in smokers with schizophrenia and bipolar disorder.

Revisiting the CME articles featured in Psychiatric Times in 2022.

While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.

From new legislation that would expand the US approach to mental health to drug abuse trends and treatment approaches for 2023, here are highlights from the week in Psychiatric Times.

What are the most pertinent drug trends to be aware of in 2023?

"We must put mental health on par with physical health and make it a basic human right, an indicator of overall health, and an industry standard.”

We may be one step closer to nonprescription naloxone.

How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?

In this CME article, explore the mental health consequences associated with the COVID-19 pandemic as well as the potential role for complementary and alternative approaches.

What is recovery?

From traumatic brain injury to the dangers of excessive social media usage, here are highlights from the week in Psychiatric Times.

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

Fentanyl is now available in ways it was not before, which may lead to fatal outcomes.

Opioid use, addiction, and overdose in youth continue to increase. What can be done?

A review of the Joint US-Canada Report on Substance Use and Harm.

The experts weighed in on a wide variety of psychiatric issues for the September 2022 issue of Psychiatric Times.

The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.